Feature | May 02, 2017 | Dave Fornell

Most Popular DAIC Content in April 2017

CMS to require AUC documentation clinical decision support for medical imaging

No. 4 on this month's list is an article about what will be required as of Jan. 1, 2018 to be reimbursed  by CMS for cardiac CT, MRI or nuclear imaging. Medicare will require documentation that appropriate use criteria (AUC) clinical decision support (CDS) was used to verify the more expensive tests are appropriate over less expensive testing options. 


May 2, 2017 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of April based on website analytics of the month’s 105,000 pageviews:  

1. FDA Harshly Criticizes Abbott, St. Jude For Failure to Address EP Device Safety

2. Cardiovascular Systems Initiates Voluntary Recall of Atherectomy Saline Infusion Pump

3. New Protocol at Henry Ford Hospital Dramatically Increases Heart Attack Survival Rates

4. CMS to Require Appropriate Use Criteria Documentation for Medical Imaging Orders

5. ACC 2017 Late-Breaking Trials

6. Echocardiography Update Document Provides New Classification Scheme for Aortic Stenosis

7. Heart Rhythm Society Late-Breaking Electrophysiology Trials Announced

8. NICE Recommends Boston Scientific CRT-Ds With EnduraLife Battery Technology for Heart Failure Treatment

9. Study Finds Significant Variability in Doctors' Angioplasty Death Rates

10. Top 5 Hottest Cardiology Technology Topics - No. 1 FDA Slams Abbott/St. Jude

11. Medtronic Initiates Global Trial Evaluating Cryoablation for Persistent Afib

12. Cardiovascular Systems Enrolls First Subject in ECLIPSE Coronary Clinical Trial

13. Alabama Medical Center First in Southeast to Offer CoreValve Evolut Pro TAVR Device

14. Boston Scientific to Acquire TAVR Maker Symetis

15. New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors

 

Most Popular Videos in April:

1. VIDEO: Editor's Choice of Most Innovative New Technology at ACC.17

2. VIDEO: Advances in Electrophysiology Technology

3. VIDEO: Cardiogenic Shock Supported With Impella Shows Good Outcomes

4. VIDEO: Bioresorbable Stent Comparable to Xience at Two Years, With Concerns

5. VIDEO: Lumedx Cardiovascular Performance Program: A New Approach to Managing Quality and Cost

 

Most Popular DAIC Content in March 2017
 

 


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now